Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes

被引:574
作者
Rane, Shweta [1 ]
He, Minzhen [1 ]
Sayed, Danish [1 ]
Vashistha, Himanshu [2 ]
Malhotra, Ashwani [2 ]
Sadoshima, Junichi [1 ]
Vatner, Dorothy E. [1 ]
Vatner, Stephen F. [1 ]
Abdellatif, Maha [1 ]
机构
[1] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, Div Nephrol, Dept Med, Newark, NJ 07103 USA
关键词
miR-199a; Hif-1 alpha Sirt1; preconditioning; PERMEABILITY TRANSITION PORE; ISCHEMIA-REPERFUSION INJURY; KINASE-C-EPSILON; PROTEIN-SYNTHESIS; MICRORNA TARGETS; GENE-EXPRESSION; FACTOR-I; RESVERATROL; HIF-1-ALPHA; CARDIOPROTECTION;
D O I
10.1161/CIRCRESAHA.108.193102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MicroRNAs are posttranscriptional gene regulators that are differentially expressed during various diseases and have been implicated in the underlying pathogenesis. We report here that miR-199a is acutely downregulated in cardiac myocytes on a decline in oxygen tension. This reduction is required for the rapid upregulation of its target, hypoxia-inducible factor (Hif)-1 alpha. Replenishing miR-199a during hypoxia inhibits Hif-1 alpha expression and its stabilization of p53 and, thus, reduces apoptosis. On the other hand, knockdown of miR-199a during normoxia results in the upregulation of Hif-1 alpha and Sirtuin (Sirt)1 and reproduces hypoxia preconditioning. Sirt1 is also a direct target of miR-199a and is responsible for downregulating prolyl hydroxylase 2, required for stabilization of Hif-1 alpha. Thus, we conclude that miR-199a is a master regulator of a hypoxia-triggered pathway and can be exploited for preconditioning cells against hypoxic damage. In addition, the data demonstrate a functional link between 2 key molecules that regulate hypoxia preconditioning and longevity. (Circ Res. 2009;104:879-886.)
引用
收藏
页码:879 / 886
页数:8
相关论文
共 36 条
[1]  
ABDELLATIF M, 1994, J BIOL CHEM, V269, P15423
[2]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[3]   Protein kinase Cε interacts with and inhibits the permeability transition pore in cardiac mitochondria [J].
Baines, CP ;
Song, CX ;
Zheng, YT ;
Wang, GW ;
Zhang, J ;
Wang, OL ;
Guo, Y ;
Bolli, R ;
Cardwell, EM ;
Ping, PP .
CIRCULATION RESEARCH, 2003, 92 (08) :873-880
[4]   HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia [J].
Berra, E ;
Benizri, E ;
Ginouvès, A ;
Volmat, V ;
Roux, D ;
Pouysségur, J .
EMBO JOURNAL, 2003, 22 (16) :4082-4090
[5]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[6]   Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α [J].
Cai, Zheqing ;
Zhong, Hua ;
Bosch-Marce, Marta ;
Fox-Talbot, Karen ;
Wang, Lei ;
Wei, Chiming ;
Trush, Michael A. ;
Semenza, Gregg L. .
CARDIOVASCULAR RESEARCH, 2008, 77 (03) :463-470
[7]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[8]   Signaling pathways in ischemic preconditioning [J].
Downey, James M. ;
Davis, Amanda M. ;
Cohen, Michael V. .
HEART FAILURE REVIEWS, 2007, 12 (3-4) :181-188
[9]   Hypoxia-inducible factor-1 is central to cardioprotection -: A new paradigm for ischemic preconditioning [J].
Eckle, Tobias ;
Koehler, David ;
Lehmann, Rainer ;
El Kasmi, Karim C. ;
Eltzschig, Holger K. .
CIRCULATION, 2008, 118 (02) :166-175
[10]   Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys [J].
Giovannini, L ;
Migliori, M ;
Longoni, BM ;
Das, DK ;
Bertelli, AAE ;
Panichi, SV ;
Filippi, C ;
Bertelli, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (03) :262-270